First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma-Reference-Cited by-同舟云学术

First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma

Published:2021-06-17 Issue:6 Volume:4 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Wang Xuechen¹²,Haaland Benjamin¹²,Hu‐Lieskovan Siwen¹³,Colman Howard¹⁴,Holmen Sheri L.¹⁵⁶^ORCID

Affiliation:

1. Huntsman Cancer Institute University of Utah Health Sciences Center Salt Lake City Utah USA

2. Department of Population Health Sciences University of Utah Salt Lake City Utah USA

3. Department of Internal Medicine University of Utah Health Sciences Center Salt Lake City Utah USA

4. Department of Neurosurgery University of Utah Health Sciences Center Salt Lake City Utah USA

5. Department of Surgery University of Utah Health Sciences Center Salt Lake City Utah USA

6. Department of Oncological Sciences University of Utah Health Sciences Center Salt Lake City Utah USA

Funder

Huntsman Cancer Foundation

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1419

Reference43 articles.

1. Cancer Statistics, 2021

2. Cancer Statistics, 2001

3. Cancer statistics, 2017

4. Review: Anti–CTLA-4 Antibody Ipilimumab: Case Studies of Clinical Response and Immune-Related Adverse Events

5. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis;Frontiers in Oncology;2024-01-09

2. Immunotherapeutic Strategies for Intra-cranial Metastatic Melanoma - a Meta-analysis and Systematic Review;Journal of Cancer;2024

3. Immunotherapy: an emerging modality to checkmate brain metastasis;Molecular Cancer;2023-07-15

4. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG;Journal for ImmunoTherapy of Cancer;2023-04